Publication

Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort.

Journal Paper/Review - Dec 26, 2022

Units
PubMed
Doi
Contact

Citation
Krauss P, Steininger K, Motov S, Sommer B, Bonk M, Cortes A, Wolfert C, Stueben G, Shiban E, Kahl K. Resection of supratentorial brain metastases with intraoperative radiotherapy. Is it safe? Analysis and experiences of a single center cohort. Front Surg 2022; 9:1071804.
Type
Journal Paper/Review (English)
Journal
Front Surg 2022; 9
Publication Date
Dec 26, 2022
Issn Print
2296-875X
Pages
1071804
Brief description/objective

Intraoperative Radiotherapy (ioRT) is an emerging treatment option in oncologic surgery for various diseases including intraaxial brain lesions to improve surgical outcome and accelerate the adjuvant oncologic therapy. Despite its use in glioma surgery, the application and data regarding ioRT in the treatment of brain metastases (BMs) is sparse. Here were report the largest series of supratentorial BMs treated with resection and ioRT according to functional outcome and adverse events.